This website is intended for journalists outside the US/UK, who are interested in media information from Boehringer Ingelheim.
Acute myeloid leukaemia (AML) is a devastating form of blood cancer that mainly affects people over 60 years old. For older patients who receive chemotherapy, the median survival is less than a year.
A perception and awareness survey of 2,520 people from France, Germany, Italy, Spain and UK. conducted in 2014 revealed urgent need to improve education about AML.